MASI News Alert Masimo Corp (MASI) 24.27 12/17/2014 01:17:27

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Masimo Corp (MASI) 24.27 $MASI

Masimo Announces Global Launch of Multigas Monitoring for the Root(R) Patient Monitoring and Connectivity Platform
Marketwired - Tue Dec 16, 7:03AM CST
Masimo (NASDAQ: MASI) today announced FDA 510(k) clearance and CE Mark of ISA(TM) OR+ multigas monitoring, a Masimo Open Connect (MOC-9) Module for the Root(R) patient monitoring and connectivity platform. During general anesthesia, the ISA OR+ monitors the inhaled and exhaled concentration of five anesthetic gas agents (Sevoflurane, Isoflurane, Halothane, Desflurane, Enflurane), carbon dioxide (CO2), nitrous oxide (N2O), and oxygen (O2), in addition to respiration rate. When technology modules are connected with Root, multiple additional parameters are available including Masimo SET(R) pulse oximetry, noninvasive and continuous hemoglobin (SpHb(R)), PVI(R), SedLine(R) brain function monitoring, and O3(TM) Regional Oximetry.*
MASI: 24.27 (+0.12)

Masimo Receives 2014 Zenith Award at the American Association of Respiratory Care Congress
Marketwired - Wed Dec 10, 7:02AM CST
Masimo (NASDAQ: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-through Motion and Low Perfusion(TM) pulse oximetry, announced today that it has received the prestigious Zenith Award for equipment and service excellence from the American Association of Respiratory Care (AARC) at the 60th Annual AARC Congress in Las Vegas, Nev.
MASI: 24.27 (+0.12)

Masimo iSpO2(TM) Pulse Oximeter Featured in Fitness Book by Tour de France Champion Greg LeMond
Marketwired - Thu Dec 04, 10:01AM CST
Masimo (NASDAQ: MASI) today announced that its award-winning iSpO2(TM) pulse oximeter is featured in the upcoming book "The Science of Fitness: Power, Performance, and Endurance," by three-time Tour de France champion Greg LeMond and co-author interventional radiologist Dr. Mark Hom, available at Amazon.com and the Elsevier Store.
MASI: 24.27 (+0.12)

Masimo's Radius-7 Monitor Gets FDA Nod, Rivalry Intensifies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 6:00PM CST
Manufacturer of patient monitoring products, Masimo Corp. (MASI) recently announced Food and Drug Administration (FDA)'s clearance of the company's Radius-7 wireless monitor.
BABY: 34.43 (-0.46), MASI: 24.27 (+0.12), CASM: 1.78 (unch), COV: 99.74 (-0.30)

FDA clears Masimo wireless patient monitor
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 2:39PM CST

MASI: 24.27 (+0.12)

Masimo Announces FDA 510(k) Clearance of Radius-7(TM)-First rainbow(R) SET(R) Noninvasive Wearable, Wireless Monitor for Root(R)
Marketwire Canada - Mon Dec 01, 12:22PM CST
Masimo (NASDAQ: MASI) today announced FDA 510(k) clearance of Radius-7(TM) for the Root(R) patient monitoring and connectivity platform, the first and only wearable, wireless monitor with Masimo's breakthrough rainbow(R) SET(R) technology, offering patients continuous monitoring with freedom of movement.
MASI: 24.27 (+0.12)

Masimo Announces FDA 510(k) Clearance of Radius-7(TM) -- First rainbow(R) SET(R) Noninvasive Wearable, Wireless Monitor for Root(R)
Marketwired - Mon Dec 01, 12:21PM CST
Masimo (NASDAQ: MASI) today announced FDA 510(k) clearance of Radius-7(TM) for the Root(R) patient monitoring and connectivity platform, the first and only wearable, wireless monitor with Masimo's breakthrough rainbow(R) SET(R) technology, offering patients continuous monitoring with freedom of movement.
MASI: 24.27 (+0.12)

Masimo to Present at 26th Annual Piper Jaffray Health Care Conference
Marketwired - Wed Nov 19, 4:01PM CST
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 26th Annual Piper Jaffray Health Care Conference at the New York Palace Hotel in New York on Tuesday, December 2, 2014, at 1:00 p.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.
MASI: 24.27 (+0.12)

Masimo Earnings Hindsight: Up 13.7% in Last 19 Days (MASI)
Comtex SmarTrend(R) - Mon Nov 17, 1:11PM CST
When Masimo (NASDAQ:MASI) reported earnings 19 days ago on October 29th, 2014, analysts, on average, expected the company to report earnings of $0.25 on sales of $144.0 million. Masimo actually reported earnings of $0.27 per share on sales of $144.1 million, beating EPS estimates by $0.02 and matching revenue estimates. Since the company's report, shares of Masimo have risen from $23.23 to $26.42, representing a gain of 13.7% in the past 19 days.
MASI: 24.27 (+0.12)

Update: Masimo Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Tue Nov 11, 1:37PM CST

MASI: 24.27 (+0.12)

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Masimo Is Up 9.9% (MASI)
Comtex SmarTrend(R) - Mon Nov 10, 12:10PM CST
When Masimo (NASDAQ:MASI) reported earnings a week ago on October 29th, 2014, analysts, on average, expected the company to report earnings of $0.25 on sales of $144.0 million. The company actually reported EPS of $0.27 on sales of $144.1 million, beating EPS estimates by $0.02 and matching revenue estimates. Since the company's report, shares of Masimo have risen from $23.23 to $25.52, representing a gain of 9.9% in the past 12 days.
MASI: 24.27 (+0.12)

Masimo (MASI) Upgraded From Hold to Buy
at The Street - Wed Nov 05, 8:13AM CST
Masimo MASI has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
MASI: 24.27 (+0.12)

New Clinical Study Shows Accuracy of Masimo Noninvasive Spot-Check Hemoglobin (SpHb(R)) in Trauma Patients
Marketwired - Wed Nov 05, 7:05AM CST
Masimo (NASDAQ: MASI) announced today that a new clinical study published in the Journal of the American College of Surgeons showed that noninvasive spot-check hemoglobin (SpHb) measurements had good correlation with invasive laboratory hemoglobin measurements in trauma patients with the potential to speed clinical decision-making to improve care, patient safety, and cost of care.(1)
MASI: 24.27 (+0.12)

Masimo Beats Q3 Earnings Estimates, Cuts Revenue Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 12:49PM CDT
Masimo Corp (MASI) reported earnings of 27 cents per share in the third quarter of 2014, which beat the Zacks Consensus Estimate by a couple of cents
ATEC: 1.31 (unch), MASI: 24.27 (+0.12), CYNO: 29.00 (+0.28), ELMD: 2.43 (-0.05)

Masimo updates guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 11:30AM CDT

MASI: 24.27 (+0.12)

Shares of MASI Down 10.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Oct 30, 10:02AM CDT
SmarTrend identified a Downtrend for Masimo (NASDAQ:MASI) on April 8th, 2014 at $26.46. In approximately 7 months, Masimo has returned 10.26% as of today's recent price of $23.74.
MASI: 24.27 (+0.12)

Masimo beats 3Q profit forecasts
Automated Insights - Thu Oct 30, 4:04AM CDT
IRVINE, Calif. (AP) _ Masimo Corp. (MASI) on Thursday reported profit of $14.9 million in its third quarter.
MASI: 24.27 (+0.12)

Masimo's (MASI) CEO Joe Kiani on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 8:50PM CDT

MASI: 24.27 (+0.12)

Masimo beats by $0.02, revenue in-line
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 3:33PM CDT

MASI: 24.27 (+0.12)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 295

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 112

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 196

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 98

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 176

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 184

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 168

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 137

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading

Top 5 Most Recently Viewed Articles

Merit Medical Systems: Price Target Raised Amid Strong Growth Prospects

Updated Category News Views 92

Merit Medical Systems Price Target Increased by Baird Baird has enhanced its price target for Merit Medical Systems, Inc. (NASDAQ: MMSI) from $96.00 to $107.00, keeping an Outperform rating on the stock. This adjustment anticipates that the company will surpass its organic growth rate and earnings per share (EPS) expectations for the upcoming quarter. Confidence in Future...

Continue Reading
Qualifacts Is Enhancing Collaborative Workspaces in Tampa

Updated Category News Views 122

Qualifacts Consolidates Tampa Operations into a Modern Office Qualifacts, a prominent player in the field of electronic health records (EHR) and data solutions tailored for behavioral health and human services organizations, has made a significant move by consolidating its two smaller offices in Tampa. The company has transitioned into a new, modern location designed to...

Continue Reading
Unlocking the Potential of Neuromarketing for Digital Strategies

Updated Category News Views 140

Understanding Neuromarketing and Its Impact In today's competitive landscape, businesses are continuously seeking ways to enhance their digital marketing strategies. One approach gaining momentum is neuromarketing, which delves into the psychology behind user behavior. A recent article from Digital Silk explores how neuromarketing principles can guide organizations in...

Continue Reading
Monkee's of Loudoun Opens to Cheers and Elegance

Updated Category News Views 187

Bringing Southern Charm to Loudoun We've all seen those places where people parade in with snooty airs and pricetags that could feed a family for a week, but this one feels different. Monkee’s of Loudoun isn’t just rolling in the racks of high fashion — it’s bringing the allure of the South with a sprinkle of luxury and empathy. This franchise is no amateur,...

Continue Reading
PG&E Critiques Senate Bill 492's Wildfire Solutions

Updated Category News Views 60

PG&E's Take on Senate Bill 492: More to Be Desired Sit down for a moment, because PG&E's not mincing words with their latest statement. Talking about Senate Bill 492, PG&E puts it plain and clear—this legislation is just skirting around the edges of what's really needed to tackle California's wildfire crisis. In their eyes, it's like putting a band-aid on a wound that...

Continue Reading